Health Care [ 12/12 ] | Health Care Equipment & Supplies [ 63/73 ]
NASDAQ | Common Stock
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.
The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow.
It also provides PhenoCycler and PhenoImager reagents; and biopharma services.
In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI.
Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 25 | -0.32 Increased by +33.33% | -0.23 Decreased by -39.13% |
| Mar 3, 25 | -0.17 Increased by +22.73% | -0.16 Decreased by -4.62% |
| Nov 14, 24 | -0.18 Increased by +31.31% | -0.20 Increased by +10.70% |
| Aug 5, 24 | -0.27 Increased by +41.30% | -0.27 |
| May 13, 24 | -0.48 Increased by +2.04% | -0.29 Decreased by -65.52% |
| Mar 4, 24 | -0.22 Increased by +56.00% | -0.27 Increased by +18.52% |
| Nov 8, 23 | -0.26 Increased by +44.68% | -0.37 Increased by +29.73% |
| Aug 7, 23 | -0.46 Increased by +2.13% | -0.44 Decreased by -4.55% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 16.64 M Decreased by -9.32% | -15.65 M Increased by +33.35% | Decreased by -94.07% Increased by +26.50% |
| Dec 31, 24 | 21.34 M Decreased by -19.42% | -8.20 M Increased by +24.10% | Decreased by -38.41% Increased by +5.81% |
| Sep 30, 24 | 18.81 M Decreased by -25.39% | -10.53 M Increased by +18.45% | Decreased by -55.98% Decreased by -9.30% |
| Jun 30, 24 | 23.16 M Decreased by -1.52% | -13.15 M Increased by +36.79% | Decreased by -56.76% Increased by +35.82% |
| Mar 31, 24 | 18.35 M Decreased by -14.29% | -23.48 M Decreased by -24.90% | Decreased by -127.98% Decreased by -45.73% |
| Dec 31, 23 | 26.49 M Increased by +24.83% | -10.80 M Increased by +42.77% | Decreased by -40.78% Increased by +54.15% |
| Sep 30, 23 | 25.21 M Increased by +33.75% | -12.92 M Increased by +27.73% | Decreased by -51.22% Increased by +45.97% |
| Jun 30, 23 | 23.52 M Increased by +31.45% | -20.80 M Decreased by -18.91% | Decreased by -88.44% Increased by +9.54% |